Mining giant Rio Tinto in talks to buy U.S. lithium producer Arcadium

This is a photograph of a Rio Tinto mining helmet taken on 2 Jun. 2020.

Aaron Bunch | Getty Images

The world’s second-largest miner Rio Tinto expressed interest in acquiring U.S. lithium producer Arcadium, the two companies confirmed in separate statements on Monday.

No financial specifics were disclosed. Rio Tinto said that there is no certainty that any transaction will be agreed to. This move comes as mining companies seek to secure essential minerals for the global energy transition.

This is a breaking news story, please check back later for more.

Source

World

Google joins Microsoft in telling users Anthropic is still available outside defense projects

March 6, 2026

Google CEO Sundar Pichai gestures to the crowd during Google’s annual I/O developers conference in Mountain View, California, on May 20, 2025. David Paul Morris | Bloomberg | Getty Images Google said it will continue offering Anthropic’s artificial intelligence technology for clients, excluding for defense work, a day after Microsoft issued a similar statement to […]

World

Market turmoil is hitting most traditional safe havens. UBS says this is the place to hide

March 6, 2026

The U.S. and Israel are showing signs of escalating their war against Iran – a move that could batter a variety of assets, even traditional safe havens. To protect their portfolios, investors can snap up stocks from an oft-shorted sector: pharmaceuticals, UBS analysts say. Since the first strikes last Saturday, the Iran War has roiled […]

World

Zealand’s stock falls 35% after disappointing drug result. Its CEO tells CNBC people need to focus less on the ‘weight loss Olympics’

March 6, 2026

Wegovy is produced by pharmaceutical company Novo Nordisk and has been approved for specifically for chronic weight management in adults and adolescents. (Photo by Steve Christo – Corbis/Corbis via Getty Images) Steve Christo – Corbis | Corbis News | Getty Images The chief executive of drugmaker Zealand Pharma sought to calm investors about the latest […]